Long-term treatment of hairy cell leukemia with interferon-α: still a viable therapeutic option
{{output}}
Classic hairy cell leukemia (HCL) is a rare indolent B‑cell-lymphoproliferative disorder, first described as a distinct disease entity in 1958. After more than two decades without effective chemotherapeutic options and a dismal prognosis of less than 5 years,... ...
